Press Releases

PerkinElmer Introduces Two New Innovative Mass Spectrometry Systems in India

><

  • NexION®NexION® 2000 ICP-MS & QSight™ LC-MS/MS

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has launched its NexION® 2000 Inductively Coupled Plasma Mass Spectrometer (ICP-MS) and QSight™ Triple Quadrupole LC/MS/MS instrument for customers in India.

The official launch announcement is being conducted in Hyderabad and will be subsequently launched in Mumbai, Ahmedabad, and Delhi, with delegates from pharma, food, academia, and other relevant market segments attending the occasion. With this, PerkinElmer has added new dimensions to its legacy of innovation for a healthier world and a technology-driven approach.

PerkinElmer has been pioneering a market specific technological platform to offer high throughput and productive solutions to customers worldwide. Mrs. Jayashree Thacker, President, PerkinElmer India & South Asia, says “With the launch of QSight instrument and NexION 2000 ICP-MS system, we have significantly broadened our analytical portfolio. We are well equipped to provide an end-to-end solution as per the application demands of the analytical industry.”

Mr. Shripad Joshi, Director, Discovery & Analytical Solutions, PerkinElmer India & South Asia, believes both these instruments are a result of PerkinElmer’s clear foresight on the needs of the market. He adds “We have always believed in designing solutions to meet the needs of our customers today and in the future. It is very important to understand the dynamics of the analytical market and help our customers prepare accordingly to help meet compliance regulatory standards related to analytical workflow in the coming years. The NexION 2000 ICP-MS system and QSight instrument are advanced solutions with a strict adherence to necessary regulatory parameters.”

About the NexION 2000 ICP-MS and QSight Instruments

The NexION 2000 ICP-MS system is specifically designed to handle any sample matrix, address any interference, and detect any particle size across a variety of applications. High levels of certain toxic elements in the environment or the food supply chain can be harmful to humans, plants, and animals. High-throughput contract lab professionals (including those for food, environmental and clinical), government and academic labs, QA/QC labs (food and pharmaceutical), and high tech and industrial labs that need elevated performance levels (semiconductor and solar) can use this system for an extensive variety of applications. With its versatile features, this ICP-MS system can help detect a broad range of elements at ultra trace levels.

  • Advanced detection limits are possible due to its highly flexible Universal Cell Technology interference removal and choice of three gas channels
  • Its sample introduction technology enables researchers to run samples with up to 35 percent total dissolved solids
  • The system delivers superior analysis times and single particle/cell detection capability – at least 10-times faster than competitive systems

The QSight instrument offers patented flow-based mass spectrometry that enables laboratories to test highly complex samples and experience increased throughput. The QSight system offers a complete solution from sample preparation to results and effective data interpretation platform for food, industrial and environmental applications. For regulatory food safety purposes, the QSight instrument specializes in detecting a wide range of pesticides that are increasingly found in crops. It can also be used for analysis of mycotoxins in food and antibiotics as well as to analyze veterinary drugs and nutritional components.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately US $2.1 billion in 2016, has about 9,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Show More

Related Articles

Close

Adblock Detected

Please consider supporting us by disabling your ad blocker